Literature DB >> 27358860

Cancer stem cells as a potential therapeutic target in breast cancer.

Mingzhi Zhang1, Zhaoming Li1, Xudong Zhang1, Yu Chang1.   

Abstract

Cancer stem cells (CSCs) are defined as the small population of cancer cells that have stem cell properties as in hierarchically organized tumors. They are considered as the source of tumor initiation and maintenance. These cells are highly resistant to current cancer treatment and may be responsible for the disease recurrence after therapy as well. Therefore, considerable efforts have been made to elucidate the molecular and pathological properties of the CSCs to develop effective therapies targeting CSCs. A growing body of experimental evidence has revealed that therapeutic targeting CSCs may offer a new strategy for patients with breast cancer (BC). In this review, we summarized the evidence for existence of CSCs, followed by an overview of their molecular biomarkers, signaling pathways and potential therapeutic strategies to target these CSCs in BC.

Entities:  

Keywords:  Cancer stem cells (CSCs); biological markers; breast cancer (BC); molecular targeted therapy

Year:  2014        PMID: 27358860      PMCID: PMC4923512          DOI: 10.3978/j.issn.2306-9759.2014.06.01

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


  106 in total

1.  CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.

Authors:  Xin-Rong Yang; Yang Xu; Bin Yu; Jian Zhou; Jia-Chu Li; Shuang-Jian Qiu; Ying-Hong Shi; Xiao-Ying Wang; Zhi Dai; Guo-Ming Shi; Bin Wu; Li-Ming Wu; Guo-Huan Yang; Bo-Heng Zhang; Wen-Xin Qin; Jia Fan
Journal:  Clin Cancer Res       Date:  2009-08-25       Impact factor: 12.531

2.  miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.

Authors:  W W Hwang-Verslues; P-H Chang; P-C Wei; C-Y Yang; C-K Huang; W-H Kuo; J-Y Shew; K-J Chang; E Y-H P Lee; W-H Lee
Journal:  Oncogene       Date:  2011-01-24       Impact factor: 9.867

3.  Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity.

Authors:  R W Storms; A P Trujillo; J B Springer; L Shah; O M Colvin; S M Ludeman; C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

4.  CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells.

Authors:  S Aigner; Z M Sthoeger; M Fogel; E Weber; J Zarn; M Ruppert; Y Zeller; D Vestweber; R Stahel; M Sammar; P Altevogt
Journal:  Blood       Date:  1997-05-01       Impact factor: 22.113

Review 5.  Breast cancer stem cells: an update.

Authors:  Jabed Iqbal; Pek Yoon Chong; Puay Hoon Tan
Journal:  J Clin Pathol       Date:  2013-01-15       Impact factor: 3.411

Review 6.  Global trends in breast cancer incidence and mortality.

Authors:  Peggy L Porter
Journal:  Salud Publica Mex       Date:  2009

Review 7.  Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.

Authors:  Madhuri Kakarala; Max S Wicha
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

8.  Heterogeneity in cancer: cancer stem cells versus clonal evolution.

Authors:  Mark Shackleton; Elsa Quintana; Eric R Fearon; Sean J Morrison
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

9.  Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells.

Authors:  Gabriela Dontu; Kyle W Jackson; Erin McNicholas; Mari J Kawamura; Wissam M Abdallah; Max S Wicha
Journal:  Breast Cancer Res       Date:  2004-08-16       Impact factor: 6.466

10.  ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.

Authors:  Ting Li; Yun Su; Yuping Mei; Qixin Leng; Bingjie Leng; Zhenqiu Liu; Sanford A Stass; Feng Jiang
Journal:  Lab Invest       Date:  2009-12-14       Impact factor: 5.662

View more
  1 in total

1.  Combined Runx2 and Snail overexpression is associated with a poor prognosis in breast cancer.

Authors:  Zhengjun Yang; Bin Zhang; Bowen Liu; Yegong Xie; Xuchen Cao
Journal:  Tumour Biol       Date:  2015-01-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.